Drug
Casimersen clinical trials
Also written SRP-4045 and AMONDYS 45.
- studies test it
- 4
- open now
- 0
- in phase 3
- 2
- first study started
- 2015
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Sarepta Therapeutics, Inc. (3) · Kevin Flanigan (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses casimersen is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)CompletedPhase 3Sarepta Therapeutics, Inc.NCT02500381Written as SRP-4045
- An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular DystrophyTerminatedPhase 3Sarepta Therapeutics, Inc.NCT03532542Written as Casimersen
- A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.CompletedPhase 2Kevin FlaniganNCT04179409Written as Amondys 45
- Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) PatientsCompletedPhase 1Sarepta Therapeutics, Inc.NCT02530905Written as SRP-4045
Codes
What other systems call casimersen · ClinicalTrials.gg INT001650
- MeSH (NLM) C000718147casimersenConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) X8UHF7SX0RCASIMERSENConfirmed FDA, NLM, Wikidata
- RxNorm 2480096One source FDA
- Wikidata Q105714904casimersenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169830CasimersenOne source FDA
- DrugBank DB14984One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000718147 | casimersen | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | X8UHF7SX0R | CASIMERSEN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2480096 | — | One source FDA |
| Wikidata | Q105714904 | casimersen | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169830 | Casimersen | One source FDA |
| DrugBank | DB14984 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.